SCHEMBL1058191

SCHEMBL1058191

CNCc1csc(CN(C(=O)O)C(C)(C)C)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
HDAC1 Q13547 5/20 0.34
HDAC6 Q9UBN7 5/20 0.34
CDK5 Q00535 5/20 0.33
CDK5R1 Q15078 5/20 0.33
ACHE P22303 1/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32
NPC1 O15118 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21812876 0.77 MMP1 (0.38) MMP1MMP2MMP9MMP13KDM4E
SCHEMBL7440479 0.77 MMP1 (0.35) MMP1MMP2MMP9MMP13RAB9A
SCHEMBL2909009 0.74 RAB9A (0.39) HDAC1HDAC6KDM4ELMNARAB9A
SCHEMBL20679753 0.73 MMP13 (0.43) MMP1MMP2MMP9MMP13HDAC1
SCHEMBL25775909 0.72 CDK4 (0.33) HDAC1HDAC6KDM4ELMNARAB9A
SCHEMBL1056063 0.71 PTPRB (0.35) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL2909010 0.70 KMT2A (0.44) KDM4ELMNARAB9ANPC1MEN1
SCHEMBL7091844 0.69 SLC6A3 (0.42) HDAC1HDAC6KDM4ELMNARAB9A
SCHEMBL21812608 0.69 CHEK1 (0.40) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL28305208 0.66 SLC6A3 (0.44) HDAC1HDAC6KDM4ELMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193227-B2 HIV protease inhibiting compounds ABBOTT LABORATORIES (US) 2012-06-05 US disclosed
US-20110003827-A1 HIV protease inhibiting compounds ABBVIE INC. 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003827-A1 HIV protease inhibiting compounds SERPINB1, HPN, DNPEP MMP1 253/4885MMP2 19/4885MMP9 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.